RheaVita

RheaVita markets an innovative continuous freeze-drying technology for (bio)pharmaceutical products. Our manufacturing approach saves companies time and money, guarantees product quality and offers the supply chain greater flexibility, compared to traditional batch freeze-drying. RheaVita sells units for R&D purposes, and full GMP systems. RheaVita also offers CDMO services: RheaVita develops freeze-drying process in a fast way with limited product consumption. We also design the optimal formulation for vaccines and biopharmaceuticals such as mRNA-LNPs, viral vectors, monoclonal antibodies, etc. RheaVita has entered a strategic partnership with IMA Life, a global provider of advanced, aseptic pharmaceutical process and production solutions. This partnership includes a financial investment and ongoing support to expand the development and commercialization of RheaVita’s technology for the global market.